Inventor · disambiguated record
Yangbing Zhao
Also filed as: ZHAO YANGBING
38 granted patents·26 pending applications·202 citations·filing 2003–2025
97Inventor score
Top patents by PatentIndex Score
64 records- 0197US10696749B2Enhancing activity of CAR T cells by co-introducing a bispecific antibodyUNIV PENNSYLVANIA·Filed 2017·Granted Jun 30, 2020·12 cites·19 claims
- 0297US9765156B2Enhancing activity of CAR T cells by co-introducing a bispecific antibodyUNIV PENNSYLVANIA·Filed 2013·Granted Sep 19, 2017·38 cites·12 claims
- 0396US11203758B2Altering gene expression in modified T cells and uses thereofUNIV PENNSYLVANIA·Filed 2018·Granted Dec 21, 2021·12 cites·16 claims
- 0496US10040846B2Compositions and methods for generating a persisting population of T cells useful for the treatment of cancerUNIV PENNSYLVANIA·Filed 2013·Granted Aug 7, 2018·39 cites·3 claims
- 0595US11208661B2Altering gene expression in modified T cells and uses thereofUNIV PENNSYLVANIA·Filed 2015·Granted Dec 28, 2021·8 cites·14 claims
- 0695US11028143B2Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory moleculesNOVARTIS AG·Filed 2015·Granted Jun 8, 2021·9 cites·16 claims
- 0795US10934336B2Use of gene editing to generate universal TCR re-directed T cells for adoptive immunotherapyUNIV PENNSYLVANIA·Filed 2018·Granted Mar 2, 2021·12 cites·22 claims
- 0895US9714278B2Use of ICOS-based CARs to enhance antitumor activity and CAR persistenceUNIV PENNSYLVANIA·Filed 2013·Granted Jul 25, 2017·34 cites·18 claims
- 0992US11795240B2Enhancing activity of CAR T cells by co-introducing a bispecific antibodyUNIV PENNSYLVANIA·Filed 2020·Granted Oct 24, 2023·2 cites·16 claims
- 1092US11299536B2Compositions and methods for generating a persisting population of T cells useful for the treatment of cancerUNIV PENNSYLVANIA·Filed 2018·Granted Apr 12, 2022·5 cites·22 claims
- 1192US10780120B2Prostate-specific membrane antigen cars and methods of use thereofUNIV PENNSYLVANIA·Filed 2019·Granted Sep 22, 2020·7 cites·3 claims
- 1290US11890301B2Methods and compositions for cells expressing a chimeric intracellular signaling moleculeUNIV PENNSYLVANIA·Filed 2016·Granted Feb 6, 2024·4 cites·8 claims
- 1390US10800840B2Compositions and methods for generating a persisting population of T cells useful for the treatment of cancerUNIV PENNSYLVANIA·Filed 2018·Granted Oct 13, 2020·4 cites·14 claims
- 1488US11274298B2RNA engineered T cells for the treatment of cancerUNIV PENNSYLVANIA·Filed 2019·Granted Mar 15, 2022·2 cites·15 claims
- 1587US11738047B2Genetically modified immune cells targeting NY-ESO-1 and methods of use thereofUNIV PENNSYLVANIA·Filed 2018·Granted Aug 29, 2023·2 cites·20 claims
- 1686US12344843B2Altering gene expression in cart cells and uses thereofUNIV PENNSYLVANIA·Filed 2020·Granted Jul 1, 2025·1 cites·8 claims
- 1786US12291707B2Modified immune cells having enhanced function and methods for screening the sameUNIV PENNSYLVANIA·Filed 2024·Granted May 6, 2025·0 cites·5 claims
- 1886US11766453B2Compositions and methods comprising prostate stem cell antigen (PSCA) chimeric antigen receptors (CARs)UNIV PENNSYLVANIA·Filed 2020·Granted Sep 26, 2023·1 cites·16 claims
- 1986US2024279665A1Altering Gene Expression in CART Cells and Uses ThereofUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 2086US2025296977A1Enhanced antigen presenting ability of car t cells by co-introduction of costimulatory moleculesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 2185US2025163132A1Compositions and methods for t cell delivery of therapeutic moleculesUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 2284US2025295774A1Compositions and methods for generating a persisting population of t cells useful for the treatment of cancerUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 2383US10981969B2Switch costimulatory receptorsJUNE CARL H·Filed 2012·Granted Apr 20, 2021·3 cites·20 claims
- 2483US10577407B2Use of ICOS-based CARS to enhance antitumor activity and CAR persistenceUNIV PENNSYLVANIA·Filed 2017·Granted Mar 3, 2020·3 cites·15 claims
- 2583US2024018271A1Enhancing Activity of CAR T Cells by Co-Introducing a Bispecific AntibodyUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 2683US2024301024A1Use of icos-based cars to enhance antitumor activity and car persistenceUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 2780US12029760B2Compositions and methods for gene editing in T cells using CRISPR/Cpf1UNIV PENNSYLVANIA·Filed 2018·Granted Jul 9, 2024·1 cites·12 claims
- 2880US2025340869A1Rna engineered t cells for the treatment of cancerUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 2978US11920130B2Modified immune cells having enhanced function and methods for screening for sameUNIV PENNSYLVANIA·Filed 2022·Granted Mar 5, 2024·0 cites·19 claims
- 3078US10828353B2Compositions and methods for T cell delivery of therapeutic moleculesUNIV PENNSYLVANIA·Filed 2015·Granted Nov 10, 2020·1 cites·23 claims
- 3178US10421960B2RNA engineered T cells for the treatment of cancerUNIV PENNSYLVANIA·Filed 2012·Granted Sep 24, 2019·2 cites·8 claims
- 3276US12350334B2Compositions and methods for generating a persisting population of T cells useful for the treatment of cancerUNIV PENNSYLVANIA·Filed 2021·Granted Jul 8, 2025·0 cites·15 claims
- 3376US2025243481A1Modified immune cells having enhanced function and methods for screening the sameUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 3476US2022170012A1Rna engineered t cells for the treatment of cancerUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 3575US2024316107A1Compositions and Methods for Gene Editing in T Cells Using CRISPR/Cpf1UNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 3675US2024342213A1Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling MoleculeUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 3774US2024041928A1Genetically Modified Immune Cells Targeting NY-ESO-1 and Methods of Use ThereofUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 3873US12404314B2Switch costimulatory receptorsUNIV PENNSYLVANIA·Filed 2019·Granted Sep 2, 2025·0 cites·15 claims
- 3973US2024041921A1Compositions and Methods Comprising Prostate Stem Cell Antigen (PSCA) Chimeric Antigen Receptors (CARs)ZHAO YANGBING·Filed 2023·Application pending·0 cites
- 4072US12162922B2Enhanced antigen presenting ability of RNA car T cells by co-introduction of costimulatory moleculesNOVARTIS AG·Filed 2021·Granted Dec 10, 2024·0 cites·22 claims
- 4172US2024026293A1Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling MoleculeUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 4271US12227555B2Use of gene editing to generate universal TCR re-directed t cells for adoptive immunotherapyUNIV PENNSYLVANIA·Filed 2021·Granted Feb 18, 2025·0 cites·17 claims
- 4371US11447769B2Modified immune cells having enhanced function and methods for screening for sameUNIV PENNSYLVANIA·Filed 2019·Granted Sep 20, 2022·0 cites·6 claims
- 4470US11958892B2Use of ICOS-based cars to enhance antitumor activity and car persistenceUNIV PENNSYLVANIA·Filed 2020·Granted Apr 16, 2024·0 cites·7 claims
- 4570US2020283729A1Treatment of cancer using chimeric antigen receptorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 4670US2023110342A1Compositions and methods of stimulating and expanding t cellsUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 4769US2025154223A1Use of gene editing to generate universal tcr re-directed t cells for adoptive immunotherapyUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 4868US12215137B2Compositions and methods for T cell delivery of therapeutic moleculesTHE TRUSTEES OF THE UNIV OF PENNSYLANIA·Filed 2020·Granted Feb 4, 2025·0 cites·21 claims
- 4967US11992503B2Prostate-specific membrane antigen cars and methods of use thereofUNIV PENNSYLVANIA·Filed 2020·Granted May 28, 2024·0 cites·21 claims
- 5064US11897966B2Mesothelin-targetting antibodies, chimeric antigen receptors, and uses thereofUTC THERAPEUTICS SHANGHAI CO LTD·Filed 2022·Granted Feb 13, 2024·0 cites·28 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yangbing Zhao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →